HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles D Burger Selected Research

lenzilumab

1/2022Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
5/2021LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
11/2020GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
6/2020First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles D Burger Research Topics

Disease

16Pulmonary Arterial Hypertension
01/2023 - 09/2014
13Pulmonary Hypertension
01/2024 - 09/2007
8COVID-19
01/2022 - 01/2020
6Lymphangioleiomyomatosis (Lymphangiomyomatosis)
07/2019 - 11/2005
5Hypertension (High Blood Pressure)
12/2022 - 06/2009
5Pneumonia (Pneumonitis)
01/2022 - 10/2005
4Lung Diseases (Lung Disease)
01/2022 - 10/2015
3Heart Failure
01/2022 - 11/2014
2End Stage Liver Disease
12/2022 - 01/2022
2Cytokine Release Syndrome
05/2021 - 06/2020
2Inflammation (Inflammations)
05/2021 - 01/2018
2Familial Primary Pulmonary Hypertension
01/2021 - 06/2009
2Respiratory Insufficiency (Respiratory Failure)
06/2020 - 02/2003
2Edema (Dropsy)
01/2020 - 07/2003
2Vascular Diseases (Vascular Disease)
09/2019 - 01/2018
2Neoplasms (Cancer)
07/2019 - 01/2018
2Infections
01/2018 - 03/2004
2Chronic Obstructive Pulmonary Disease (COPD)
03/2017 - 04/2009
1Chronic Renal Insufficiency
01/2024
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2022
1Congenital Heart Defects (Congenital Heart Defect)
01/2022
1Diabetes Mellitus
01/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2020
1Systemic Scleroderma (Systemic Sclerosis)
09/2019
1Rare Diseases (Rare Disease)
07/2019
1Lymphangiomyoma
07/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2018
1Disease Progression
01/2018
1Cysts
10/2015
1Ureteral Obstruction
10/2015
1Chylothorax
10/2015
1Myalgia
11/2014

Drug/Important Bio-Agent (IBA)

4lenzilumabIBA
01/2022 - 06/2020
4Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 06/2020
4Oxygen (Dioxygen)IBA
05/2021 - 04/2009
4lipoarabinomannan (LAM)IBA
07/2019 - 10/2015
4Sirolimus (Rapamycin)FDA Link
07/2019 - 01/2011
3treprostinilFDA Link
01/2023 - 03/2017
2SodiumIBA
12/2022 - 07/2015
2Phosphodiesterase 5 InhibitorsIBA
04/2022 - 11/2014
2Monoclonal AntibodiesIBA
01/2022 - 06/2020
2fibrin fragment D (D-dimer)IBA
05/2021 - 06/2009
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
09/2019 - 09/2014
2Prostaglandins IIBA
03/2018 - 01/2016
2Epoprostenol (Prostacyclin)FDA LinkGeneric
03/2018 - 09/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2024
1Iloprost (Ventavis)FDA Link
01/2023
1BilirubinIBA
12/2022
1PowdersIBA
04/2022
1Endothelin Receptor AntagonistsIBA
04/2022
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
04/2022
1riociguatIBA
04/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1VaccinesIBA
01/2022
1SteroidsIBA
01/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021
1ChemokinesIBA
05/2021
1CytokinesIBA
05/2021
1remdesivirIBA
05/2021
1Ferritins (Ferritin)IBA
05/2021
1Angiotensin Receptor AntagonistsIBA
01/2021
17-(N-(3-aminopropyl)amino)heptan-2-oneIBA
01/2021
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021
1Investigational DrugsIBA
11/2020
1ambrisentanFDA Link
01/2020
1Nifedipine (Adalat)FDA LinkGeneric
09/2019
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2019
1HLA-DPA1 antigen (HLA DPA1)IBA
01/2019
1Brain Natriuretic Peptide (Natrecor)FDA Link
05/2018
1Biomarkers (Surrogate Marker)IBA
05/2018
1AutoantibodiesIBA
01/2018
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2018
1Anesthetics (Anesthetic Agents)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1macitentanIBA
07/2017
1Estrogens (Estrogen)FDA Link
06/2017
1Aromatase InhibitorsIBA
06/2017
1Tadalafil (Cialis)FDA Link
11/2014
1Sildenafil Citrate (Viagra)FDA Link
11/2014

Therapy/Procedure

16Therapeutics
04/2022 - 09/2014
4Liver Transplantation
12/2022 - 07/2003
3Artificial Respiration (Mechanical Ventilation)
01/2022 - 07/2003
2Mechanical Ventilators (Ventilator)
05/2021 - 06/2006
2Aftercare (After-Treatment)
07/2019 - 08/2018
2Transplantation
10/2005 - 03/2004
1Contraindications
12/2022
1Home Nursing (Nursing, Home)
01/2022
1Intravenous Infusions
05/2021
1Investigational Therapies (Experimental Therapy)
12/2020
1Resuscitation
01/2020
1Durable Medical Equipment (Medical Equipment, Durable)
01/2016
1Pleurodesis
10/2015
1Lung Transplantation
10/2015
1Central Venous Catheters
11/2014